Michael John Casamento
Executive Vice President of Finance & Chief Financial Officer at Amcor
Thanks, Ron, and hello, everyone. Turning to our Flexibles segment performance on slide six. Our Flexibles business had another excellent quarter with all business units delivering solid organic sales growth while executing well on inflation recovery, cost initiatives and mix management. Net sales were up 6% on a reported basis, which includes recoveries of higher raw material costs of approximately $270 million, representing 10% of quarterly sales growth. The teams have continued to successfully manage the pass-through of higher raw material costs. And as expected, the related price cost impact on earnings for the quarter was relatively neutral. Excluding the raw material impact, organic revenue growth of 3% was driven by favorable price mix benefits of approximately 4%, partly offset by lower volumes. Some business units experienced lower demand in certain categories during the quarter.
However, our broad market coverage and geographic diversification limited the overall volume impact. Sales across our combined priority segments grew high single digits for the quarter, with health care a particular standout, delivering strong sales and volume growth across every region. In our Asian business, overall volumes were higher than the prior year despite lower volumes in China, which was impacted by ongoing COVID-related lockdowns. Adjusted EBIT was up 11% in comparable constant currency terms for the quarter, reflecting overall sales growth, price mix benefits and outstanding cost performance, including quick actions taken to flex the cost base in regions where the operating environment has been more challenged. Adjusted EBIT margin of 12.7% was comparable to last year, notwithstanding the 130 basis point dilution related to increased sales dollars associated with passing through high raw material costs.
Turning to Rigid Packaging on slide seven. The key takeaway for Rigids is the business delivered another quarter of solid sales and earnings growth. Reported sales were up 19%, which included the pass-through of higher raw material costs of approximately $130 million or 17% of sales. Excluding this pass-through, organic sales growth of 3% was driven by price mix benefits of 2% and volume growth of 1%. In North America, we had positive product mix in the beverage business with hot-fill volumes up 6%, reflecting growth across a range of categories, including sports drinks, juices and ready-to-drink teas. From an overall standpoint, beverage volumes were lower than last year, reflecting a decrease in lower value cold fill and preform volumes. In the Specialty Container business, volumes increased mid-single digits led by strength in health care, dairy and nutrition markets. And in Latin America, volumes were up high-single digits with strong performance in key countries such as Argentina, Brazil and Mexico.
Adjusted EBIT increased 7% on a comparable constant currency basis driven by higher overall volumes, strong inflation recovery and continued solid operating and cost performance. EBIT margins were 7% and over the past several quarters have been negatively impacted by approximately 250 basis points due to a sharp increase in resin pricing being passed through the sales line and significantly increasing sales dollars as a result. In terms of the balance sheet on slide eight, we continue to maintain a strong investment-grade credit rating, which provides us with flexibility to invest for growth and access to lower cost debt markets across key currencies. Leverage at the end of the quarter was three times and right in line with our expectations for this time of year given the seasonality of cash flow. And as we highlighted in August, free cash flow was lower than the same quarter last year as we expected.
Our cash flow is typically weighted to the second half of the year. And in fiscal 2023, the seasonality will be more pronounced given higher raw material costs and the decision to increase inventory levels through last year to offset some of the volatility created by supply constraints. We have reaffirmed our full year cash flow guidance with Cranes, which I'll come back to shortly. Notwithstanding the temporary increase in inventory levels, we remain highly focused on working capital performance, which is particularly critical in this inflationary environment, and we've maintained our 12-month average working capital sales ratio at 8%. In August, we announced an incremental investment in ePAC and the purchase of a Flexibles plant in the Czech Republic and funded both of those investments in the September quarter for a total of around USD100 million. And while we did not repurchase any shares during Q1, we continue to expect to allocate approximately $400 million towards share repurchases in fiscal '23.
Turning now to Amcor's outlook for fiscal '23 on slide nine. While we expect market conditions to remain challenging through 2023, we have had a strong start to the year. And taking into account the relative stability of our end market exposures and our strong track record of consistent execution, we remain confident in our ability to deliver against the outlook we provided in August. We have reaffirmed our expectations for organic growth of 5% to 10% from the underlying business and a benefit of approximately 2% from share repurchases while continuing to expect an impact from the following three nonoperating items. Firstly, a negative impact of approximately 4% from higher interest expense after tax. Forward curve expectations have continued to move higher and interest expense is now expected to be in the range of $240 million to $260 million. Net of our expectations for a slightly lower effective tax rate, we continue to expect a 4% headwind to EPS, as we noted in August.
Second, an estimated 2% negative impact from the scale down and sale of our three plants in Russia, which we continue to expect in the second half of the fiscal year. And third, a negative currency translation impact of 5%, which is higher than the 2% we anticipated back in August due to the continued strengthening of the U.S. dollar. As a result of this U.S. dollar strengthening, we are updating our expectations for adjusted EPS on a reported basis to be $0.77 to $0.81 per share. In terms of cash flow, we continue to expect a seasonally stronger second half, and we have reaffirmed our adjusted free cash flow expectations to a range of approximately $1 billion to $1.1 billion. However, the stronger U.S. dollar pushes our current expectation toward the lower end of the range. So in summary for me today, the business has delivered another strong quarter of organic sales and earnings growth as we remain focused on executing for our customers, managing margins and taking decisive actions to rapidly recover inflation while flexing our cost base. Our ability to successfully balance these priorities supports our confidence in delivering another year of solid underlying growth despite persistent market challenges.
With that, I'll hand back to Ron.